Urogastrone/epidermal growth factor in treatment of congenital microvillous atrophy.
D004815:Epidermal Growth Factor / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007410:Intestinal Diseases / Q000151:congenital* / Q000188:drug therapy; D011994:Recombinant Proteins / Q000627:therapeutic use*
D011994:Recombinant Proteins; D004815:Epidermal Growth Factor